Patent details

EP2911684 Title: IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES

Basic Information

Publication number:
EP2911684
PCT Application Number:
US2013066424
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP138495817
PCT Publication Number:
WO2014066527
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES
French Title of Invention:
FORMES D'IL-15R ALPHA, CELLULES EXPRIMANT DES FORMES D'IL-15R ALPHA, ET UTILISATIONS THÉRAPEUTIQUES D'IL-15R ALPHA ET DE COMPLEXES IL-15/IL-15R ALPHA
German Title of Invention:
IL-15R-ALPHA-FORMEN, IL-15R-ALPHA-FORMEN EXPRIMIERENDE ZELLEN UND THERAPEUTISCHE VERWENDUNG VON IL-15R-ALPHA UND IL-15/IL-15R-ALPHA-KOMPLEXEN
SPC Number:

Dates

Filing date:
23/10/2013
Grant date:
19/06/2019
EP Publication Date:
02/09/2015
PCT Publication Date:
01/05/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/06/2019
EP B1 Publication Date:
19/06/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/10/2019
Expiration date:
23/10/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/06/2019
 
 

Name:
NOVARTIS AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:
The United States of America, as represented by The Secretary, Department of Health and Human Services
Address:
The Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660, Bethesda, MD 20892-7660, United States (US)

Inventor

1

Name:
FELBER, Barbara, K.
Address:
United States (US)

2

Name:
VOURNAKIS, John, N.
Address:
United States (US)

3

Name:
PAVLAKIS, George, N.
Address:
United States (US)

4

Name:
FINKIELSZTTEIN, Sergio
Address:
United States (US)

Priority

1

Priority Number:
201261718169 P
Priority Date:
24/10/2012
Priority Country:
United States (US)

2

Priority Number:
201361820035 P
Priority Date:
06/05/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/20; A61P 35/00; A61P 35/04; A61P 37/04;

Publication

European Patent Bulletin

1

Issue number:
201925
Publication date:
19/06/2019
Description:
Grant (B1)

2

Issue number:
202227
Publication date:
06/07/2022
Description:
Termination of the opposition

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages